Free Trial

Theravance Biopharma (TBPH) News Today

$8.75
+0.09 (+1.04%)
(As of 06/21/2024 ET)
Theravance Biopharma logo with Medical background
Park West Asset Management LLC Sells 1,083,251 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Park West Asset Management LLC lowered its holdings in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 54.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 900,000 shares of the biopharm
Theravance Biopharma logo with Medical background
Theravance Biopharma (NASDAQ:TBPH) Lowered to "Hold" at StockNews.com
StockNews.com cut Theravance Biopharma from a "buy" rating to a "hold" rating in a research report on Thursday.
Theravance Biopharma logo with Medical background
Theravance Biopharma (NASDAQ:TBPH) Cut to Hold at StockNews.com
StockNews.com cut Theravance Biopharma from a "buy" rating to a "hold" rating in a research report on Tuesday.
StockNews.com Upgrades Theravance Biopharma (NASDAQ:TBPH) to "Buy"
StockNews.com raised shares of Theravance Biopharma from a "hold" rating to a "buy" rating in a research report on Monday.
HC Wainwright Reaffirms Buy Rating for Theravance Biopharma (NASDAQ:TBPH)
HC Wainwright restated a "buy" rating and set a $20.00 price target on shares of Theravance Biopharma in a research report on Tuesday.
Theravance Biopharma (TBPH) to Release Earnings on Monday
Theravance Biopharma (NASDAQ:TBPH) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=591386)
Zacks Research Analysts Reduce Earnings Estimates for Theravance Biopharma, Inc. (NASDAQ:TBPH)
Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Stock analysts at Zacks Research lowered their FY2024 EPS estimates for shares of Theravance Biopharma in a report issued on Monday, April 15th. Zacks Research analyst K. Shah now forecasts that the biopharmaceutical company will post earni
Theravance Biopharma, Inc. (NASDAQ:TBPH) to Post Q1 2026 Earnings of $0.29 Per Share, Zacks Research Forecasts
Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Research analysts at Zacks Research upped their Q1 2026 EPS estimates for shares of Theravance Biopharma in a research report issued on Monday, April 15th. Zacks Research analyst K. Shah now expects that the biopharmaceutical company will p
Vanguard Group Inc. Sells 379,627 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Vanguard Group Inc. trimmed its holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 9.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,839,329 shares of the biopharmaceutical compa
Theravance Biopharma (NASDAQ:TBPH) Stock Price Crosses Below Fifty Day Moving Average of $9.04
Theravance Biopharma (NASDAQ:TBPH) Stock Crosses Below 50 Day Moving Average of $9.04
Equities Analysts Offer Predictions for Theravance Biopharma, Inc.'s Q1 2024 Earnings (NASDAQ:TBPH)
Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Analysts at Zacks Research decreased their Q1 2024 earnings per share (EPS) estimates for shares of Theravance Biopharma in a report issued on Wednesday, March 13th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical
Theravance Biopharma, Inc. (NASDAQ:TBPH) Forecasted to Earn FY2026 Earnings of $0.75 Per Share
Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Research analysts at Zacks Research issued their FY2026 earnings per share estimates for shares of Theravance Biopharma in a report issued on Wednesday, March 13th. Zacks Research analyst K. Shah forecasts that the biopharmaceutical company
Jacobs Levy Equity Management Inc. Has $3.52 Million Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Jacobs Levy Equity Management Inc. lessened its holdings in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 31.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 407,525
Theravance Biopharma, Inc. (NASDAQ:TBPH) Forecasted to Earn Q1 2024 Earnings of ($0.40) Per Share
Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2024 earnings per share estimates for shares of Theravance Biopharma in a research note issued on Tuesday, March 5th. Leerink Partnrs analyst D. Risinger anticipates that the bio
FY2026 EPS Estimates for Theravance Biopharma, Inc. Raised by Leerink Partnrs (NASDAQ:TBPH)
Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Equities research analysts at Leerink Partnrs lifted their FY2026 earnings per share estimates for Theravance Biopharma in a research note issued on Tuesday, March 5th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceu
Theravance Biopharma Inc (TBPH)
Theravance Biopharma Q4 2023 Earnings Preview
Theravance Biopharma (NASDAQ:TBPH) Stock Price Passes Below 200-Day Moving Average of $9.83
Theravance Biopharma (NASDAQ:TBPH) Share Price Passes Below Two Hundred Day Moving Average of $9.83
Theravance Biopharma, Inc. (TBPH)
Get Theravance Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for TBPH and its competitors with MarketBeat's FREE daily newsletter.

Do you think trading w/emotion helps? (Ad)

Holding onto our losers too long and cutting our winners at the first sign of profit. Steven recognized that the only way to really solve this problem was to build an automated trading bot using a machine that has zero emotion.

Click here to join Steven LIVE this week.

TBPH Media Mentions By Week

TBPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TBPH
News Sentiment

1.00

0.71

Average
Medical
News Sentiment

TBPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TBPH Articles
This Week

0

2

TBPH Articles
Average Week

Get Theravance Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for TBPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TBPH) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners